Melanoma By The State: Texas
Melanoma, don’t mess with Texas! That’s essentially the rallying cry of volunteers, medical institutions, foundations, and other interested groups…
03/08/2021
Melanoma By The State: Texas
Melanoma, don’t mess with Texas! That’s essentially the rallying cry of volunteers, medical institutions, foundations, and other interested groups…
|
03/08/2021
Survivor Spotlight: Acral Melanoma Survivor
Melanoma Can Hide in the Most Unlikely Places By Mara Klecker Lisa first noticed a pale band on her right…
|
02/23/2021
In Plain English—COVID-19, the vaccines, and melanoma: What do melanoma patients and their families need to know?
By Kim Margolin, M.D. Coronavirus is novel (new), and the vaccines are even newer, so little melanoma-specific information is…
|
02/23/2021
A Letter From Our Vice President | February 2021
From the Desk of Alicia Rowell, Vice President Hope, love, cure. That’s our theme this February, in honor of Valentine’s…
02/05/2021
Alkermes Announces FDA Orphan Drug Designation for Nemvaleukin Alfa for Treatment of Mucosal Melanoma
March 11, 2021| Source: PRNewswire Alkermes plc (Nasdaq: ALKS) today announced that nemvaleukin alfa (“nemvaleukin”, formerly referred to as…
|
|
02/05/2021
“A Celebration of Friendship” Solo Exhibit Shares Heartfelt Story While Raising Funds for AIM at Melanoma Foundation
Contact: Chris Miller (972) 788-2599 Publicity cjmiller@rainmakeradv.com (RICHARDSON, TEXAS) How do we honor the meaning of friendship and the potential…
|
|
02/05/2021
Survivor Spotlight: Mark Lewis, Stage III Melanoma Survivor
A Partner Through It All By Mara Klecker Mark Lewis was less than a year into his relationship when he…
|
02/05/2021
Art Exhibit to Honor a Friendship and Raise Funds for AIM
By Mara Klecker Melanie Brannan has had difficulty falling asleep in recent weeks. Throughout the day and into the night,…
|
|
01/26/2021
FDA Grants Toripalimab Fast Track Designation for Mucosal Melanoma
January 24, 2021 19:07 ET | Source: Junshi Biosciences Junshi Biosciences (HKEX: 1877; SSE: 688180), an innovation-driven biopharmaceutical…
|
|
01/10/2021
In Plain English—Intratumoral Injection: Boosting the immune response against metastatic melanoma by the direct injection of immunotherapy into tumor masses
By Kim Margolin, M.D. Using the patient’s own immune system to combat melanoma is a powerful tool for patients…
|
Recent Posts
Jan. 13, 2026
The Integrative Care Approach
Jan. 13, 2026
Improved Response to Immunotherapy with COVID-19 mRNA Vaccines
Dec. 09, 2025
One Day at a Time: Caregiving Through Ocular Melanoma
Nov. 24, 2025
A Life Rewritten: Finding Strength in the Face of Melanoma
Nov. 20, 2025